Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.12 EUR | -0.58% | -0.33% | +3.06% |
Jun. 07 | AbbVie's tight grip on Humira market raises concerns about biosimilars | RE |
Jun. 05 | Dpa-AFX Overview: COMPANIES from 05.06.2024 - 15:15 | DP |
Sales 2024 * | 19.56B 21.01B | Sales 2025 * | 20.3B 21.81B | Capitalization | 11.48B 12.33B |
---|---|---|---|---|---|
Net income 2024 * | 665M 714M | Net income 2025 * | 964M 1.04B | EV / Sales 2024 * | 1.09 x |
Net Debt 2024 * | 9.86B 10.59B | Net Debt 2025 * | 8.99B 9.65B | EV / Sales 2025 * | 1.01 x |
P/E ratio 2024 * |
17.3
x | P/E ratio 2025 * |
11.9
x | Employees | 117,128 |
Yield 2024 * |
2.7% | Yield 2025 * |
3.35% | Free-Float | 67.83% |
Latest transcript on Fresenius Medical Care AG
1 day | -0.58% | ||
1 week | -0.33% | ||
Current month | -0.15% | ||
1 month | -3.17% | ||
3 months | +5.22% | ||
6 months | +2.54% | ||
Current year | +3.06% |
Managers | Title | Age | Since |
---|---|---|---|
Helen Giza
CEO | Chief Executive Officer | 56 | 19-10-31 |
Martin Fischer
DFI | Director of Finance/CFO | 47 | 23-09-30 |
Franklin Maddux
CTO | Chief Tech/Sci/R&D Officer | 65 | 08-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 57 | 16-05-11 |
Shervin Korangy
BRD | Director/Board Member | 50 | 23-07-13 |
Marcus Kuhnert
BRD | Director/Board Member | 56 | 23-07-13 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.48% | 202 M€ | -.--% | ||
1.12% | 2 M€ | +13.56% | - | |
0.80% | 79 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-11 | 39.12 | -0.58% | 319,697 |
24-06-10 | 39.35 | -1.01% | 319,741 |
24-06-07 | 39.75 | +0.91% | 367,307 |
24-06-06 | 39.39 | +0.56% | 232,924 |
24-06-05 | 39.17 | +0.08% | 270,917 |
Delayed Quote Xetra, June 11, 2024 at 11:42 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.06% | 12.4B | |
+24.25% | 89.38B | |
-24.01% | 75.67B | |
+6.34% | 28.83B | |
+4.85% | 18.25B | |
-13.14% | 16.51B | |
+2.09% | 15.72B | |
+79.55% | 13.71B | |
+79.66% | 13.46B | |
+21.81% | 12.64B |
- Stock Market
- Equities
- FME Stock